A recent study by the National Institutes of Health (NIH) has found a link between two common 'forever chemicals' and an increased risk of aggressive breast cancer. The study, which analyzed data from over 3,800 women, found that those with higher levels of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in their blood were more likely to develop estrogen receptor-negative (ER-negative) breast cancer. ER-negative breast cancer is a more aggressive form of the disease, with poorer outcomes than tumors that respond to estrogen. The study's findings suggest that exposure to these chemicals could be one contributing factor to the development of this type of cancer. The researchers used data from the Sister Study, a large research project conducted by the NIH's National Institute of Environmental Health Sciences. They analyzed blood samples from 1,609 women who developed breast cancer and compared them to a group of 2,269 women who did not develop the disease. The study found that women in the highest PFOA exposure group had a 67% higher rate of ER-negative breast cancer than women in the lowest group. The association was even stronger for PFOS, with the highest exposure group showing a 93% higher rate. While the study did not find a clear link between the chemicals and breast cancer risk overall, the findings suggest that exposure to these substances could be a contributing factor to the development of aggressive breast cancer. The researchers emphasize that exposure to PFAS is not necessarily unavoidable and that people can take steps to reduce their exposure. The study's lead author, Alexandra White, Ph.D., noted that the findings could eventually help identify new ways to reduce the risk of aggressive breast cancer. The researchers are also interested in understanding how these chemicals might influence cancer development and are planning further investigations to clarify the strength of the observed associations and identify whether certain populations face greater risks. The study's findings highlight the importance of understanding how environmental exposures may contribute to aggressive forms of breast cancer and add to growing questions about the long-term health effects of 'forever chemicals'.